Clinical Trial Update: Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia [Phase 3]

View source ↗

Summary

This document reports the completion and posting of results for a Phase 3 monotherapy trial of brexpiprazole in adults with early-episode schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Brexpiprazole (Rexulti) (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2016-03-29